NEWSLETTER
ARE YOU LOOKING FOR CAREER OPPORTUNITIES IN BIOMEDICAL RESEARCH?

COME MEET US AT OUR MSCA-IF BOOTCAMP
CHECK OUR OPEN OPPORTUNITIES HERE
IF YOU WANT TO PURSUE A CAREER IN EXCELLENCE SCIENCE WHILE IMPROVING PATIENTS’ HEALTH, IDIBELL IS YOUR PLACE
The Bellvitge Institute of Biomedical Research (IDIBELL) is one of the most dynamic health research institutes in Barcelona, Spain. Striving to attain significant improvements in human health, it boasts more than 800 researchers in the fields of translational, clinical and epidemiological research. IDIBELL is a member of the International Campus of Excellence of the University of Barcelona HUBc. It is also part of the CERCA institution of the Generalitat of Catalonia.
IDIBELL is a joint research initiative that manages the research activities of researchers at the University Hospital of Bellvitge, the Catalan Institute of Oncology, and the University of Barcelona-Bellvitge Campus. The research carried out by IDIBELL is structured in four areas: cancer, neuroscience, translational medicine and regenerative medicine. There are also about 70 research groups, which are organised into nine programmes.
IDIBELL is the proud recipient of the “HR Excellence in Research” logo from the European Commission. We greatly value emerging talents, and we are continuously enlarging our research community.
WE ARE CURRENTLY LOOKING FOR EXPERIENCED RESEARCHERS INTERESTED IN SECURING A POSTDOCTORAL MSCA-IF FELLOWSHIP

GERMANY’S SOUTHWEST IS TOP IN EU RESEARCH FUNDING

With 18 of 52 Consolidator Grants, Baden-Württemberg, Germany’s Southwest, is the most successful country in the EU Research Council's Europe-wide competition. This is clear evidence of the excellence and innovative power of the researchers and of the best research conditions in the state.
The result puts the state at the top of the German states, well ahead of Bavaria (twelve) and North Rhine-Westphalia (seven). Consolidator Grants offer outstanding scientists the opportunity to raise up to two million euros for a research project lasting up to five years.
18 applications from universities and research institutions in Baden-Württemberg were successful in the sixth call for proposals of this funding line in the EU programme for research and innovation "Horizon 2020" (2014-2020).
Among the awarded institutions is the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions, and Europe’s flagship laboratory for the life sciences. Founded in 1974, EMBL is an intergovernmental organisation with more than 80 independent research groups covering the spectrum of molecular biology. It operates across six sites: Heidelberg, Barcelona, Hamburg, Grenoble, Rome and EMBL-EBI Hinxton.

The main laboratory is located in the beautiful city of Heidelberg in the German Southwest. It was inaugurated in 1978 as the first EMBL facility dedicated to basic molecular biology research, technology development, service provision and advanced training. Today more than 800 staff members work at EMBL Heidelberg, in services and administration, in a truly international, innovative and interdisciplinary environment, and across five research units:
• Cell Biology and Biophysics
• Developmental Biology
• Genome Biology • Structural and Computational Biology
• Directors' Research
Get to know the outstanding researchers who have been awarded funding across the different ERC core grant schemes during their time at EMBL.
The EMBL is one out of more than 100 research institutions in Baden-Württemberg.
Baden-Württemberg is proud to be this year’s partner for the MCAA and its members.

Find out more about career opportunities in Baden-Württemberg on www.bw-career.de.